Quinolone resistance markers in fluoroquinolone-resistant, non-ESBL- producing Escherichia coli isolated from non-human primates at selected zoological gardens and tourist centres

被引:0
作者
Okunlade A.O. [1 ]
Adekanmbi A.O. [2 ,4 ]
Olajumoke J.F. [1 ]
Osemuohu O.A. [3 ]
机构
[1] Department of Veterinary Microbiology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan
[2] Environmental Microbiology and Biotechnology Laboratory, Department of Microbiology, University of Ibadan
[3] Department of Pharmaceutical Microbiology, University of Ibadan, Ibadan
[4] Molecular Biology and Biotechnology Laboratory, Department of Microbiology, University of Ibadan, Ibadan
关键词
fluoroquinolone resistant E. coli; PMQR; Primates;
D O I
10.1080/00207233.2022.2088963
中图分类号
学科分类号
摘要
Fluoroquinolone-resistant Escherichia coli (E. coli) from faecal matter of non-human primates (NHP) and their carriage of plasmid-mediated quinolone resistance genes were investigated in this study. Faecal samples were collected from six accredited zoological and tourism gardens in South-western and Northern Nigeria. Five fluoroquinolone-resistant E. coli were obtained from the 43 NHP sampled. Three of the isolates were from Agodi gardens, Ibadan, and one each from Osun Osogbo grove and University of Ibadan Zoological garden. The isolates were from Green monkeys (3), Mona Monkey (1) and Anubis baboon (1). They showed varying antibiotic resistance levels, with 100% resistance observed only towards sulfamethoxazole-trimethoprim. None of the isolates was positive for ESBL production. All the isolates carried qnrD, with three each carrying qnrA and qnrS. Only one isolate carried qnrB. The carriage of qnr genes by captive animals could portend serious public health risks. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码:687 / 698
页数:11
相关论文
共 33 条
  • [1] Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., Woodford N., CTX-M: Changing the face of ESBLs in Europe, Journal of Antimicrobial Chemotherapy, 59, 2, pp. 165-174, (2007)
  • [2] Strahilevitz J., Jacoby G.A., Hooper D.C., Robicsek A., Plasmid-mediated quinolone resistance: A multifaceted threat, Clinical Microbiology Reviews, 22, 4, pp. 664-689, (2009)
  • [3] Platell J.L., Cobbold R.N., Johnson J.R., Heisig A., Heisig P., Clabots C., Trott D.J., Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia, Antimicrobial Agents and Chemotherapy, 55, 8, pp. 3782-3787, (2011)
  • [4] Webber M., Piddock L.J., Quinolone resistance in Escherichia coli, Veterinary Research, 32, 3-4, pp. 275-284, (2001)
  • [5] Da Costa P.M., Belo A., Goncalves J., Bernardo F., Field trial evaluating changes in prevalence and patterns of antimicrobial resistance among Escherichia coli and Enterococcus spp. isolated from growing broilers medicated with enrofloxacin, apramycin and amoxicillin, Veterinary Microbiology, 139, 3-4, pp. 284-292, (2009)
  • [6] Wasyl D., Hoszowski A., Zajac M., Szulowski K., Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughter, Frontiers in Microbiology, 4, (2013)
  • [7] Mandell G.L., Uptake, transport, delivery, and intracellular activity of antimicrobial agents, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 25, 12P2, pp. 130S-133S, (2005)
  • [8] Shahcheraghi F., Nobari S., Rahmati G.F., Nasiri S., Owlia P., Nikbin V.S., Imani Fooladi A.A., First report of New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Iran, Microbial Drug Resistance, 19, 1, pp. 30-36, (2013)
  • [9] Piddock L.J., Mechanisms of fluoroquinolone resistance: An update 1994–1998, Drugs, 58, 2, pp. 11-18, (1999)
  • [10] Soussy C.J., Wolfson J.S., Ng E.Y., Hooper D.C., Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus, Antimicrobial Agents and Chemotherapy, 37, 12, pp. 2588-2592, (1993)